
CLIENTS





Dyax Pharmaceuticals (now Shire) was faced with a problem. They needed a way to effectively communicate important information about their drug for Hereditary Angioedema (Kalbitor) and called Lever.Media to help construct a messaging platform to instruct physicians and patients.



Dyax Pharmaceuticals (now Shire) was faced with a problem. They needed a way to effectively communicate important information about their drug for Hereditary Angioedema (Kalbitor) and called Lever.Media to help construct a messaging platform to instruct physicians and patients.





